Clinical Trial Update: Phase I Clinical Study of ZL-82 Tablets [Phase 1]

View source ↗

Summary

A Phase I clinical trial of ZL-82 tablets for rheumatoid arthritis and inflammatory bowel disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Rheumatoid Arthritis

Drugs mentioned

• ZL-82 tablets

Snippet

Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Conditions: Rheumatoid Arthritis (RA), Inflammatory Bowel Disease - IBD1 | Phase 1 | Status: COMPLETED